- Home
- IPW vs PTN Comparison
IPW vs PTN Comparison
Compare IPW & PTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPW
- PTN
- Stock Information
- Founded
- IPW 2018
- PTN 1986
- Country
- IPW United States
- PTN United States
- Employees
- IPW N/A
- PTN N/A
- Industry
- IPW Catalog/Specialty Distribution
- PTN Biotechnology: Pharmaceutical Preparations
- Sector
- IPW Consumer Discretionary
- PTN Health Care
- Exchange
- IPW Nasdaq
- PTN Nasdaq
- Market Cap
- IPW 21.7M
- PTN 25.4M
- IPO Year
- IPW 2021
- PTN 1993
- Fundamental
- Price
- IPW $0.60
- PTN $1.00
- Analyst Decision
- IPW Strong Buy
- PTN Strong Buy
- Analyst Count
- IPW 1
- PTN 1
- Target Price
- IPW $2.75
- PTN $7.00
- AVG Volume (30 Days)
- IPW 49.4K
- PTN 1.7M
- Earning Date
- IPW 02-13-2025
- PTN 02-13-2025
- Dividend Yield
- IPW N/A
- PTN N/A
- EPS Growth
- IPW N/A
- PTN N/A
- EPS
- IPW N/A
- PTN N/A
- Revenue
- IPW $80,844,081.00
- PTN $350,000.00
- Revenue This Year
- IPW $8.31
- PTN N/A
- Revenue Next Year
- IPW $77.15
- PTN N/A
- P/E Ratio
- IPW N/A
- PTN N/A
- Revenue Growth
- IPW N/A
- PTN N/A
- 52 Week Low
- IPW $0.40
- PTN $0.68
- 52 Week High
- IPW $3.65
- PTN $3.99
- Technical
- Relative Strength Index (RSI)
- IPW 32.58
- PTN 50.51
- Support Level
- IPW $0.60
- PTN $0.99
- Resistance Level
- IPW $0.71
- PTN $1.08
- Average True Range (ATR)
- IPW 0.05
- PTN 0.14
- MACD
- IPW -0.00
- PTN 0.01
- Stochastic Oscillator
- IPW 1.10
- PTN 35.59
About IPW iPower Inc.
iPower Inc is online hydroponic equipment and accessory retailer and supplier in North America. The company sells products through own website as well as online channel partners that include Amazon, Walmart, and eBay.
About PTN Palatin Technologies Inc.
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.